期刊
FASEB JOURNAL
卷 36, 期 -, 页码 -出版社
WILEY
DOI: 10.1096/fasebj.2022.36.S1.L7587
关键词
-
资金
- Structural Genomics Consortium [1097737]
- Bayer AG, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Genome Canada through Ontario Genomics Institute [OGI-196]
- EU/EFPIA/OICR/McGill/KTH/Diamond Innovative Medicines Initiative 2 Joint Undertaking [875510]
- Janssen, Merck KGaA (aka EMD in Canada and US)
- Pfizer
- Takeda